Literature DB >> 1695124

Effect of osmotic pressure on uptake of chemotherapeutic agents by carcinoma cells.

R L Stephen1, J M Novak, E M Jensen, C Kablitz, S S Buys.   

Abstract

Intraperitoneal chemotherapy has been used to treat cancers which are confined to the abdominal cavity. Several variables which affect drug delivery into tumor cells have been identified, but the effect of osmotic pressure has not been studied. Tumor cell lines were used to evaluate the effect of fluid tonicity on drug uptake. HeLa cells and a murine teratoma cell line were suspended in solutions of tonicities 154, 308, and 616 mosM, each containing the same quantity of 5-fluorouracil, and uptake of the drug was measured at different intervals over 30 min. At all time points the amount of 5-fluorouracil taken up by cells in solutions of 154 mosM was greater than that in 310 mosM solutions, which was greater than the uptake in 616 mosM solutions, each by an average of 40-50%. Incorporation of drug into tumor cells was also assayed in vivo using a teratoma cell line propagated i.p. in mice. Tumor cell uptake of doxorubicin was increased to a similar extent when this drug was administered in hypotonic solutions of 154 mosM and was decreased by administration in hypertonic solutions of 465 mosM, as compared to solutions of 310 mosM. These results demonstrate that the uptake of chemotherapeutic agents into tumor cells is increased significantly when these drugs are infused in solutions of lower osmolalities, a finding which may be exploited in clinical situations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1695124

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Evaluating the role of admixture in cancer therapy via in vitro drug response and multivariate genome-wide associations.

Authors:  John Jack; Tammy M Havener; Howard L McLeod; Alison A Motsinger-Reif; Matthew Foster
Journal:  Pharmacogenomics       Date:  2015-08-28       Impact factor: 2.533

2.  Intrapleural hypotonic cisplatin treatment for malignant pleural mesothelioma: in vitro experiments and clinical application.

Authors:  Tetsuzo Tagawa; Ichiro Yoshino; Masafumi Yamaguchi; Atsushi Osoegawa; Toshifumi Kameyama; Seiichi Fukuyama; Takuro Kometani; Yoshihiko Maehara
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

3.  Inhibition of BRCA2 and Thymidylate Synthase Creates Multidrug Sensitive Tumor Cells via the Induction of Combined "Complementary Lethality".

Authors:  Mateusz Rytelewski; Peter J Ferguson; Saman Maleki Vareki; Rene Figueredo; Mark Vincent; James Koropatnick
Journal:  Mol Ther Nucleic Acids       Date:  2013-03-12       Impact factor: 10.183

Review 4.  Stressing mitosis to death.

Authors:  Andrew Burgess; Mina Rasouli; Samuel Rogers
Journal:  Front Oncol       Date:  2014-06-04       Impact factor: 6.244

5.  Tumor suppression in basal keratinocytes via dual non-cell-autonomous functions of a Na,K-ATPase beta subunit.

Authors:  Julia Hatzold; Filippo Beleggia; Hannah Herzig; Janine Altmüller; Peter Nürnberg; Wilhelm Bloch; Bernd Wollnik; Matthias Hammerschmidt
Journal:  Elife       Date:  2016-05-30       Impact factor: 8.140

6.  Hypotonic intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in mice.

Authors:  A Kondo; M Maeta; A Oka; S Tsujitani; M Ikeguchi; N Kaibara
Journal:  Br J Cancer       Date:  1996-05       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.